MCRI's BCG vaccine trial joins global race to better understand COVID-19 variants
(Murdoch Childrens Research Institute) An Australian-led study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 8, 2021 Category: Infectious Diseases Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

South Africa: We Need to Do for TB Vaccines What We've Done for Covid-19
[spotlight] It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 21, 2021 Category: Infectious Diseases Source Type: news

Animals are our overlooked allies in the fight against Covid | Melanie Challenger
It ’s important to recognise the vital role they’ve played in development of vaccines and treatmentsA few weeks ago, I received my first shot of a vaccine against Covid-19. As the newly vaccinated exited the clinic, there was a mix of relief and elation on people ’s faces. We exchanged little smiles of solidarity. If we could have burst into spontaneous applause, I’m sure we would have done.Recently, the lead scientist for the Oxford/AstraZeneca vaccine, Prof Sarah Gilbert,was honoured with the RSA Albert Medal. There are rumours that Gilbert ’s team, along with the pioneers of the mRNA vaccin...
Source: Guardian Unlimited Science - May 17, 2021 Category: Science Authors: Melanie Challenger Tags: Medical research Vaccines and immunisation Coronavirus Animals Science World news Source Type: news

South Africa: SA At Cutting Edge of TB Vaccine Research
[spotlight] It is a hundred years since the BCG (Bacille Calmette-Guerin) vaccine, the only registered vaccine proven to offer some protection against tuberculosis , was first used in people. A relative shortage of public funding and little interest from pharmaceutical companies to develop new unprofitable TB vaccines has frustrated scientific research in this area for most of the last century. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 26, 2021 Category: African Health Source Type: news

TB vaccine may protect newborns against other infectious diseases
(London School of Hygiene& Tropical Medicine) The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in Lancet Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 17, 2021 Category: Infectious Diseases Source Type: news

Tuberculosis Kills As Many People Each Year As COVID-19. It ’ s Time We Found a Better Vaccine
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Tuberculosis Kills As Many People Each Year As COVID-19. It’s Time We Found a Better Vaccine appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - January 15, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health TerraViva United Nations tuberculosis Source Type: news

If Covid-19 is Primarily a ‘First World’ Virus, Why is the Global South in Lockdown?
A lockdown closer home. Secretary-General Antonio Guterres walking the empty corridors of the UN Secretariat building in New York in 2020. Credit: United NationsBy Darini Rajasingham-SenanayakeCOLOMBO, Sri Lanka, Jan 7 2021 (IPS) The currently available Covid-19 vaccines have been authorized for ‘emergency use ‘in Europe and North America. This is due to an apparent spike in Covid-19 flu cases in the northern hemisphere as winter advances. Highly advertised vaccines are being produced and rolled out at ‘warped speed’ by powerful pharmaceutical and bio-technology companies headquartered in Euro-Ameri...
Source: IPS Inter Press Service - Health - January 7, 2021 Category: International Medicine & Public Health Authors: Darini Rajasingham-Senanayake Tags: Aid Development & Aid Editors' Choice Featured Global Headlines Health Human Rights IPS UN: Inside the Glasshouse Population Poverty & SDGs TerraViva United Nations Source Type: news

Persistent pollutants linked to poor vaccine response
New research indicates that exposure to pollutants such as DDT and PCBs may dampen infants’ immune response to the tuberculosis vaccine. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - January 6, 2021 Category: Environmental Health Source Type: news

Why Africa ’s COVID-19 Outbreak Hasn’t Been as Bad as Everyone Feared
When COVID-19 initially blazed through Asia, Europe and then the United States, global public health experts worried that it could be catastrophic for Africa, with its crowded cities, poorly funded health sector and lack of testing facilities. The U.N. Economic Commission for Africa in April predicted up to 300,000 deaths this year if the virus couldn’t be contained on the continent. Yet it was the U.S, with its superior health system, that hit that grim milestone first, and so far, Africa has been largely spared the worst of the devastation experienced by the rest of the world. As of Dec. 29, the Africa Centres for ...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 Londontime Source Type: news

Vaccination against tuberculosis can reduce the spread of COVID-19 and ease its course
(St. Petersburg State University) St Petersburg University scientists have analysed about 100 academic papers and statistics on the incidence of COVID-19 in different countries of the world. Analysis of these data showed that the spread of the new coronavirus infection occurs more slowly where there is a large percentage of people vaccinated against tuberculosis with the BCG vaccine. Moreover, this vaccination itself, given in early childhood, changes the immune system in such a way that the new coronavirus disease course tends to be less severe. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 3, 2020 Category: Infectious Diseases Source Type: news

Battles Won – and Lost – Against AIDS Hold Valuable Lessons for Managing COVID-19
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Battles Won – and Lost – Against AIDS Hold Valuable Lessons for Managing COVID-19 appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 30, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health World AIDS Day Source Type: news

Could the TB Vaccine Help Prevent COVID-19?
WEDNESDAY, Nov. 25, 2020 -- A widely used tuberculosis vaccine may help protect people against the new coronavirus or reduce the severity of COVID-19, a new study suggests. The Bacillus Calmette-Gu érin (BCG) was developed in the early 1900s and is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 25, 2020 Category: General Medicine Source Type: news

BCG Vaccination Linked to Lower SARS - CoV - 2 Seroprevalence
Seroprevalence of anti - SARS - CoV - 2 IgG lower for health care workers with history of BCG vaccination (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 24, 2020 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pediatrics, Pulmonology, Journal, Source Type: news

BCG Vaccination Linked to Lower SARS-CoV-2 Seroprevalence
TUESDAY, Nov. 24, 2020 -- History of Bacillus Calmette-Guérin (BCG) vaccination is associated with decreased seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) among health care workers... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 24, 2020 Category: Pharmaceuticals Source Type: news

Study: TB vaccine linked to lower risk of contracting COVID-19
(Cedars-Sinai Medical Center) A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already approved by the U.S. Food and Drug Administration may help prevent coronavirus infections or reduce severity of the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 20, 2020 Category: Infectious Diseases Source Type: news

Infographic: How Vaccines Train Innate Immunity
A recent study eludidates some of the changes that occur in the body after inoculation with a tuberculosis vaccine. (Source: The Scientist)
Source: The Scientist - November 1, 2020 Category: Science Tags: Infographics Magazine Issue Source Type: news

Africa: The Slow Motion Race for a TB Vaccine
[spotlight] If the world had forgotten the importance of vaccines, COVID-19 has served as a stark reminder. Less than a year after the emergence of SARS-CoV-2 (the virus that causes COVID-19), over a hundred vaccine candidates are under development and several large clinical trials are already under way, including some in South Africa. It is plausible that a safe and effective COVID-19 vaccine will be available within the next year or two, although only time and properly conducted trials will tell. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - October 19, 2020 Category: Infectious Diseases Source Type: news

COVID-19: Examining Theories for Africa ’ s Low Death Rates
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post COVID-19: Examining Theories for Africa’s Low Death Rates appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - October 11, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health Source Type: news

Could BCG vaccine protect against COVID-19? UK recruitment begins
(University of Exeter) A largescale global trial designed to test the theory that the widely-used BCG vaccine could help protect against COVID-19 will soon recruit healthcare staff and care home workers in the UK. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 11, 2020 Category: International Medicine & Public Health Source Type: news

UK study tests if BCG tuberculosis vaccine protects against coronavirus
Bacillus Calmette-Guerin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been shown to protect against infection or severe illness with other respiratory pathogens. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2020 Category: Pharmaceuticals Source Type: news

Dartmouth TB Vaccine Moves Forward After Successful Phase 2 Trial
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - September 29, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release Research Tanzania tubercolosis Source Type: news

Successful Dartmouth TB Vaccine Moves Forward After Phase 2 Trial
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - September 29, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release Research Tanzania tubercolosis Source Type: news

Successful Dartmouth TB vaccine moves forward after phase 2 trial
(The Geisel School of Medicine at Dartmouth) Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted among 650 adolescents in Tanzania, a nation with high rates of TB infection, and showed that the vaccine was safe and induced immune responses against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 29, 2020 Category: Infectious Diseases Source Type: news

Researchers uncover early results about an existing tuberculosis vaccine that has been hypothesized to help against the coronavirus
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts. This has led many researchers to suspect that BCG vaccine, which immunizes against tuberculosis, might offer protection against COVID-19. (Source: World Pharma News)
Source: World Pharma News - September 21, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Vaccination insights
(University of California - Santa Barbara) While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts. This has led many researchers to suspect that BCG vaccine, which immunizes against tuberculosis, might offer protection against COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 21, 2020 Category: Infectious Diseases Source Type: news

BCG vaccine safe for elderly, can protect against respiratory infections: Study
However the study, published in the journal Cell, cautioned that it is unclear whether the vaccine can prevent COVID-19 in the older sections of the population. (Source: The Economic Times)
Source: The Economic Times - September 2, 2020 Category: Consumer Health News Source Type: news

Elderly people protected against respiratory infections by BCG vaccine
(Radboud University Medical Center) The BCG vaccine has a broad, stimulating effect on the immune system. This gives it an effective preventive action against various infections - possibly also against COVID-19. New studies are investigating that. BCG is frequently given to children, but a double-blind randomized clinical study, a collaboration between Radboud university medical center and the National and Kapodistrian University of Athens shows that elderly people also benefit from it. The results are published in Cell. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 1, 2020 Category: Biology Source Type: news

TB vaccine shows encouraging results against coronavirus in phase-3 clinical trials
VPM1002, a tuberculosis vaccine, is showing encouraging results against the coronavirus infection in phase-III clinical trials being conducted in Germany. (Source: The Economic Times)
Source: The Economic Times - August 12, 2020 Category: Consumer Health News Source Type: news

Significantly improved COVID-19 outcomes in countries with higher TB vaccination coverage
(American Associates, Ben-Gurion University of the Negev) The researchers discovered that BCG regimes are associated with better COVID-19 outcomes, both in reducing infection rates and death rates per million, especially for ages 24 or younger who had received the vaccination in the last 15 years. There was no effect among older adults who had received the BCG vaccine. Many countries have stopped inoculating their entire population, but some still use BCG widely. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 12, 2020 Category: Infectious Diseases Source Type: news

BCG shots could slow down Covid-19 spread in first thirty days, says study
The paper published in Science Advances, a peer-reviewed medical journal brought out by the American Association for the Advancement of Science, said that countries with mandatory Bacillus Calmette-Gu érin (BCG) vaccination showed “slower infection and death rates” during the first 30 days of the Covid-19 outbreak in their country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 1, 2020 Category: Pharmaceuticals Source Type: news

Mandatory country-wide BCG vaccination found to correlate with slower growth rates of COVID-19 cases
(American Association for the Advancement of Science) Scientists have found that countries with mandatory Bacillus Calmette-Gu é rin (BCG) vaccination until at least the year 2000 tended to exhibit slower infection and death rates during the first 30 days of the outbreak (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 31, 2020 Category: Infectious Diseases Source Type: news

Serum Institute conducting phase III clinical trial of tuberculosis vaccine: DBT
The BCG vaccine is administered routinely to all newborns as part of the national childhood immunisation programme to prevent tuberculosis (TB), an infection caused by bacteria that mainly affects the lungs. It has beneficial heterologous effects and proven antiviral and immune modulatory properties that protect against infectious diseases through induction of trained innate immunity and heterologous adaptive immunity. (Source: The Economic Times)
Source: The Economic Times - July 26, 2020 Category: Consumer Health News Source Type: news

Notes from the Field: Effects of the COVID-19 Response on Tuberculosis Prevention and Control Efforts - United States, March-April 2020
This report describes the importance of continuing to provide resources for tuberculosis testing during the COVID-19 pandemic. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 23, 2020 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Tuberculosis (TB) Tuberculosis Vaccine (BCG) COVID-19 Coronavirus Disease 2019 Source Type: news

Bovine TB vaccine trials get go-ahead in England and Wales
Scientific breakthrough could lead to phasing out of badger culling to tackle diseaseField trials of a cattle vaccine for bovine tuberculosis have been given the go-ahead as part of moves to phase out badger culling to tackle the disease.The trials are due to get under way in England and Wales to accelerate deployment of a cattle vaccine for TB by 2025, the government announced on Wednesday.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 22, 2020 Category: Science Authors: PA Media Tags: Bovine tuberculosis Animal welfare Animals Environment Farming Rural affairs UK news Badgers Science Source Type: news

BCG vaccine being tried for Covid-19 elderly individuals in hotspots in India
The study sponsored by the ICMR will recruit 1,450 elderly individuals within the ages of 60 and 99 with no preexisting conditions such as diabetes and will run across six centers in India. The hypothesis for the BCG vaccine comes from studies that have shown that the vaccine — besides protecting children against tuberculosis — also has non-specific effects against other respiratory tract infections. (Source: The Economic Times)
Source: The Economic Times - July 15, 2020 Category: Consumer Health News Source Type: news

TN to launch trial to study efficacy of BCG vaccine to reduce COVID-19 mortality for elders
This is significant as the study will see whether the vaccine ’s potential to combat Covid-19 and prevent hospitalisation among the aged as they are more susceptible to picking up the infection as they often suffer from co-morbid conditions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Evidence Shows TB Vaccine May Help Versus COVID-19
Developing countries have lower-than-expected COVID-19 death rates, and a TB vaccine given in countries with high rates of tuberculosis might play a significant role in reducing COVID-19 death rates. (Source: WebMD Health)
Source: WebMD Health - July 13, 2020 Category: Consumer Health News Source Type: news

Evidence Mounts That TB Vaccine Might Help Protect Against COVID-19
MONDAY, July 13, 2020 -- A tuberculosis vaccine may help reduce the risk of death from COVID-19, researchers suggest. Developing countries have lower-than-expected COVID-19 death rates, and a TB vaccine given in countries with high rates of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 13, 2020 Category: General Medicine Source Type: news

More evidence emerges that a TB vaccine might help fight coronavirus
More research emerged this week in potential support of using the tuberculosis vaccine Bacillus Calmette-Guerin (BCG) as a tool in the fight against coronavirus. (Source: CNN.com - Health)
Source: CNN.com - Health - July 10, 2020 Category: Consumer Health News Source Type: news

Preliminary study suggests tuberculosis vaccine may be limiting COVID-19 deaths
(Virginia Tech) While a direct correlation between BCG vaccinations and a reduction in coronavirus mortalities still needs to be understood more fully, researchers hold hope that the BCG vaccine might be able to provide at least short-term protections against severe COVID-19, particularly for front-line medical workers or high-risk patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2020 Category: International Medicine & Public Health Source Type: news

Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus
SPRING HOUSE, PENNSYLVANIA, June 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today its decision to discontinue the Phase 3 LOTUS study of STELARA® (ustekinumab) in Systemic Lupus Erythematosus (SLE) due to lack of efficacy in SLE.The decision is based on data from a pre-planned interim efficacy analysis. Interim safety findings were consistent with the known safety profile of STELARA, and no new safety signals were identified. Investigators, study participants and health authorities have been informed of the decision. The company intends to thoroughly analyze the totality of...
Source: Johnson and Johnson - June 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

South Africa: New Multi-Functional TB Blood Test Validated
[UCT] Researchers from the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT), the Center for Global Infectious Disease Research - Seattle in the United States, and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to serve multiple functions in the fight against TB. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 25, 2020 Category: Infectious Diseases Source Type: news

A Vaccine Against COVID-19 Would Be the Latest Success in a Long Scientific History
Here’s betting you wouldn’t want anyone blowing smallpox scabs up your nose. But you might feel differently if you lived in 15th century China. Long ago, the Chinese recognized that people who had contracted smallpox once were immune to reinfection. They came up with the idea of preserving scabs from individuals who had suffered mild cases, drying them out, crushing them to a powder and blowing them up the nostril. For boys it was the right nostril, for girls it was the left because, well, 15th century. That is how the story of vaccines usually begins, though that version is decidedly incomplete. For one thing,...
Source: TIME: Science - May 15, 2020 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Explainer health Source Type: news

Africa: Could BCG, a 100-Year-Old Vaccine for Tuberculosis, Protect Against Coronavirus?
[IPS] This week, the Bill and Melinda Gates Foundation announced it will donate A$10 million to help fund an Australian trial testing whether a very old vaccine, BCG, can be used against a new threat, COVID-19. So what is the BCG vaccine and what might its place be in the fight against coronavirus? (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 15, 2020 Category: Infectious Diseases Source Type: news

Could BCG, a 100-year-old Vaccine for Tuberculosis, Protect Against Coronavirus?
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Could BCG, a 100-year-old Vaccine for Tuberculosis, Protect Against Coronavirus? appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - May 14, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news

Mandatory BCG vaccination may make COVID-19 less virulent in India, suggests study
The bacille Calmette-Gurin (BCG) vaccine has a documented protective effect against meningitis and disseminated TB in children, according to the World Health Organisation. It is part of the mandatory childhood immunization programme in many countries including India. (Source: The Economic Times)
Source: The Economic Times - May 7, 2020 Category: Consumer Health News Source Type: news

Researchers unlock TB vaccine puzzle in findings that could save millions of newborns
(University of British Columbia) An international research team has identified the mechanism behind one of science's most enduring mysteries: what makes the 100-year-old tuberculosis (TB) vaccine so effective at preventing newborn deaths from diseases other than TB? (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 6, 2020 Category: Infectious Diseases Source Type: news

An Old TB Vaccine Finds New Life in Coronavirus Trials
Studies are underway to test whether giving a shot of BCG vaccine could protect doctors and nurses against COVID-19. (Source: The Scientist)
Source: The Scientist - May 4, 2020 Category: Science Tags: News & Opinion Source Type: news

A $10 million grant enables BCG vaccine trial to expand internationally, enroll 10,000 healthcare workers
(Murdoch Childrens Research Institute) An A$10 million grant from the Bill& Melinda Gates Foundation will allow the Murdoch Children's Research Institute's (MCRI) clinical trial of the BCG vaccine against COVID-19 to extend to 10,000 healthcare workers across Australia, Spain and The Netherlands. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 4, 2020 Category: Infectious Diseases Source Type: news